Risk factors for the occurrence of spina bifida (a case-control study) and the prevalence rate of spina bifida in Japan

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 97, Issue 9, 2013, Pages 610-615

  Kondo, Atsuo ^a   Morota, Nobuhito ^b   Ihara, Satoshi ^c   Saisu, Takeshi ^d   Inoue, Katsumi ^e   Shimokawa, Shoko ^f   Fujimaki, Hiroya ^g   Matsuo, Keisuke ^h   Shimosuka, Yoichi ⁱ   Watanabe, Tomoyuki ^j  

^a Tsushima Rehabilitation Hospital   (Japan)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d CHIBA CHILDREN'S HOSPITAL   (Japan)

^e UNIVERSITY OF MIYAZAKI   (Japan)

^f ST MARY S HOSPITAL   (Japan)

^g MAEBASHI RED CROSS HOSPITAL   (Japan)

^h Kitakyushu Rehabilitation Center for Children with Disabilities   (Japan)

ⁱ Komaki Shimin Hospital   (Japan)

^j AICHI GAKUIN UNIVERSITY   (Japan)

more..

Author keywords

Case control study; Folic acid; Prevalence; Risk factors; Spina bifida; Supplements

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; FOLIC ACID; VALPROIC ACID;

ARTICLE; BODY MASS; CLINICAL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; JAPAN; JAPANESE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; PROGENY; QUESTIONNAIRE; RISK FACTOR; SPINAL DYSRAPHISM; STILLBIRTH; THIRD DEGREE RELATIVE;

CASE-CONTROL STUDY; FOLIC ACID; PREVALENCE; RISK FACTORS; SPINA BIFIDA; SUPPLEMENTS;

ANTICONVULSANTS; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; HUMANS; INFANT, LOW BIRTH WEIGHT; JAPAN; LOGISTIC MODELS; ODDS RATIO; PEDIGREE; PREGNANCY; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SPINAL DYSRAPHISM;

EID: 84884718724     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23179     Document Type: Article

References (26)

1. Berry RJ, Bailey L, Mulinare J, Bower C. 2010. Fortification of flour with folic acid. Food Nutr Bull 31(Suppl);S22-S35.
2. Berry RJ, Li Z, Erickson JD, et al. 1999. Prevention of neural-tube defects with folic acid in China. N Engl J Med 341:1485-1490.
3. Botto L, Moore CA, Khoury MJ, Erickson JD. 1999. Neural tube defects. N Engl J Med 341:1509-1519.
4. Botto LD, Lisi A, Robert-Gnansia E, et al. 2005. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ 330:571-573.
5. Chatkupt S, Skurnick JH, Jaggi M, et al. 1994. Study of genetics, epidemiology, and vitamin usage in familial spina bifida in the United States in the 1990s. Neurology 44:65-70.
6. De Wals P, Tairou F, Van Allen MI, et al. 2007. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 357:135-142
7. Goggin T, Gough H, Bissessar A, et al. 1987. A comparative study of the relative effects of anticonvulsant drugs and dietary folate on the red cell folate status of patients with epilepsy. QJ Med 65:911-919.
8. Hertrampf E, Cortes E. 2008. National food-fortification program with folic acid in Chile. Food Nutr Bull 29:S231-S237. ICBDSR Annual Report 2011. Available at: http://www.icbdsr.org/filebank/documents/ar2005/Report2011.pdf. Accessed April 2013.
9. Japan Association of Obstetricians and Gynecologists. 2011. The annual report of congenital malformations of 2010. (In Japanese) Yokohama: Japan Association of Obstetricians and Gynecologists.
10. Kaneko S, Battino D, Andermann E, et al. 1999. Congenital malformations due to antiepileptic drugs. Epilepsy Res 33:145-158.
11. Knudsen VK, Orozova-Bekkevold I, Rasmussen LB, et al. 2004. Low compliance with recommendations on folic acid use in relation to pregnancy: is there a need for fortification? Public Health Nutr 7:843-850
12. Kondo A, Yamamoto S, Inoue H, et al. 2009. Folic acid in the prevention of neural tube defects: awareness among laywomen and healthcare providers in Japan. Congenit Anom 49:97-101.
13. Mass Media Database Service. 2013. Available at: http://www.nifty.com/RXCN/ (In Japanese). Accessed April 2013.
14. Meador KL, Baker GA, Browning N, et al. 2009. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 360:1597-1605.
15. Mills JL, Signore C. 2004. Neural tube defect rates before and after food fortification with folic acid. Birth Defects Res A Clin Mol Teratol 70:844-845
16. Ministry of Health, Labour, and Welfare. 2000. Information to women of childbearing age on consumption of folic acid in order to reduce children affected with neural tube defects. (In Japanese) Tokyo: Ministry of Health, Labour, and Welfare.
17. Ministry of Health, Labour, and Welfare. 2002. Maternal and child health handbook. Available at: http://www.mhlw.go.jp/shingi/2002/01/s0115-2.html (In Japanese). Accessed May 2013.
18. Ministry of Health, Labour, and Welfare. 2010. Statistics on births of children. Available at: http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/tokusyu/syussyo06/index.html (In Japanese). Accessed March 2013.
19. Mitchell LE, Adzick NS, Melchionne J, et al. 2004. Spina bifida. Lancet 364:1885-1895.
20. Mosley BS, Cleves MA, Siega-Roz AM, et al. 2009. Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United Sates. Am J Epidemiol 169:9-17
21. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the medical research council vitamin study. Lancet 338:131-137.
22. Oakley GP Jr. 2007. When will we eliminate folic acid-preventable spina bifida? Epidemiology 18:367-368.
23. Sayed AR, Bourne D, Pattinson R, Henderson B. 2008. Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Res A Clin Mol Teratol 82:211-216
24. Shurtleff D, Lemire R, Warkany J. 1986. Embryology, etiology, and epidemiology. In: Shurtleff D, editor. Myelodysplasias and exstrophies: significance, prevention, and treatment. Orlando: Grune and Stratton. pp. 39-64.
25. Simpson JL, Bailey LB, Pietrzik K, et al. 2010. Micronutrients and women of reproductive potential: required dietary intake and consequences of dietary deficiency or excess. Part I: folate, vitamin B12, Vitamin B6. J Matern Fetal Neonatal Med 23:1323-1343. Available at: http://www.mhlw.go.jp/houdou/2006/02/dl/h0201-3a3-03c.pdf. Accessed April 2013.
26. Wilson RD, Davies G, Desilets V, et al. 2003. The use of folic acid for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 25:959-965.